Prof. NESLİHAN ÇOBAN

Publication Network

Articles 48

1. Evaluation of gene and microRNA expression patterns in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension as rare diseases

Inci E., Ozuynuk-Ertugrul A. S., Ekici B., Koseoglu-Buyukkaya P., Kocak A., Çoban N.

Respiratory Medicine , vol.248, 2025 (SCI-Expanded, Scopus)

2. Sperm RNA quantity and PRM1, PRM2, and TH2B transcript levels reflect sperm characteristics and early embryonic development.

Ozsaıt Selcuk B. Ş., Bulgurcuoglu-Kuran S., Sever-Kaya D., Coban N., Aktan G., Kadioglu A.

Asian journal of andrology , 2024 (SCI-Expanded, Scopus)

3. Genetic variants of ANRIL and coronary artery disease: Insights from a Turkish study population.

Ozuynuk-Ertugrul A. S., Kirsan C. B., Erkan A. F., EKİCİ B., Komurcu-Bayrak E., ÇOBAN N.

Gene , vol.917, pp.148475, 2024 (SCI-Expanded, Scopus) Sustainable Development

4. The minor allele of ANGPTL8 rs2278426 has a protective effect against CAD in T2DM patients

Bilgin A. G., EKİCİ B., Ozuynuk-Ertugrul A. S., Erkan A. F., ÇOBAN N.

Gene , vol.914, 2024 (SCI-Expanded, Scopus)

5. Examining the effects of coronary artery disease- and mitochondrial biogenesis-related genes' and microRNAs' expression levels on metabolic disorders in epicardial adipose tissue

Dogan N., Ozuynuk-Ertugrul A. S., BALKANAY O. O., YILDIZ C. E., Guclu-Geyik F., Kirsan C. B., et al.

GENE , vol.895, 2024 (SCI-Expanded) Sustainable Development

6. Alteration of circulating miRNAs during myocardial infarction and association with lipid levels.

Ozuynuk-Ertugrul A. S., Ekici B., Erkan A. F., Coban N.

Laboratory medicine , 2023 (SCI-Expanded)

7. Association of Intelectin 1 Gene rs2274907 A > T Polymorphism with Obesity, Type 2 Diabetes, Serum Intelectin-1 Levels and Lipid Profiles in Turkish Adults

Guclu-Geyik F., Koseoglu P., Guven G., Can G., KAYA A., ÇOBAN N., et al.

Biochemical Genetics , vol.61, no.6, pp.2276-2292, 2023 (SCI-Expanded, Scopus) Sustainable Development

8. Investigation of miR-26a-5p and miR-19a-3p expression levels in angiographically confirmed coronary artery disease

ÇOBAN N., Erkan A. F. F., Ozuynuk-Ertugrul A. S., Ekici B.

ACTA CARDIOLOGICA , 2023 (SCI-Expanded, Scopus)

9. Effect of Mitochondrial Dysfunction on Coronary Artery Disease - Part 2

Doğan N., ÇOBAN N.

Türk Kardiyoloji Derneği Arşivi , vol.51, no.3, pp.202-211, 2023 (ESCI, Scopus, TRDizin)

10. Genetic Evaluation of Mitochondria Dysfunction in Coronary Artery Disease: Part 1 Koroner Arter Hastalığında Mitokondri İşlev Bozukluğunun Genetik Açıdan İncelenmesi: Bölüm 1

Doğan N., ÇOBAN N.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , vol.51, no.2, pp.135-145, 2023 (Scopus)

11. Identification of the pathogenic effects of missense variants causing PRKAG2 cardiomyopathy

Komurcu-Bayrak E., Kalkan M. A., Coban N., Ozsait-Selcuk B. Ş., Bayrak F.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS , vol.727, 2022 (SCI-Expanded, Scopus)

12. Examining the expression levels of ferroptosis-related genes in angiographically determined coronary artery disease patients

Ozuynuk A. S., Erkan A. F., Coban N., Unaltuna N.

MOLECULAR BIOLOGY REPORTS , vol.49, no.8, pp.7677-7686, 2022 (SCI-Expanded, Scopus) Sustainable Development

13. Association of polymorphisms in the sex hormone genes with the presence and severity of coronary artery disease

Coban N., Ozuynuk A. S., Erkan A. F., KAYA A., EKİCİ B., Guclu-Geyik F., et al.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.50, no.1, pp.22-33, 2022 (ESCI) Sustainable Development

14. Examining the effects of the CLU and APOE polymorphisms' combination on coronary artery disease complexed with type 2 diabetes mellitus

Ozuynuk A. S., Erkan A. F., Doğan N., EKİCİ B., Erginel-Unaltuna N., Kurmus O., et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS , vol.36, no.1, 2022 (SCI-Expanded, Scopus) Sustainable Development

15. Val109Asp polymorphism in Intelectin 1 gene is associated with coronary artery disease severity in women

Guclu-Geyik F., Erkan A. F., Ozuynuk A. S., Ekici B., Coban N.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.50, no.1, pp.34-46, 2022 (ESCI) Sustainable Development

16. Levels of miR-130b-5p in peripheral blood are associated with severity of coronary artery disease

Coban N., Ozuynuk A. S., Erkan A. F., Guclu-Geyik F., Ekici B.

MOLECULAR BIOLOGY REPORTS , vol.48, no.12, pp.7719-7732, 2021 (SCI-Expanded, Scopus) Sustainable Development

17. Cholesterol-related gene variants are associated with diabetes in coronary artery disease patients

Ozuynuk A. S., Erkan A. F., EKİCİ B., Erginel-Unaltuna N., Coban N.

MOLECULAR BIOLOGY REPORTS , vol.48, pp.3945-3954, 2021 (SCI-Expanded) Sustainable Development

18. ROR-Alpha May Indirectly Regulate Insulin Resistance Related Lipid Metabolism Genes Through miR-19a-3p And miR-26a-5p in Simvastatin Treatment

Coban N., Gulec C.

METABOLISM-CLINICAL AND EXPERIMENTAL , vol.116, pp.89, 2021 (SCI-Expanded, Scopus)

19. Apolipoprotein E and adiponectin levels in coronary artery disease patients with low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol discordance

KURMUŞ FERİK Ö., ERKAN A. F., ÇOBAN N., KAYA A., ADEMOĞLU E.

International Journal of Medical Biochemistry , vol.4, no.2, pp.85-90, 2021 (Scopus, TRDizin)

20. The rs2175898 Polymorphism in theESR1Gene has a Significant Sex-Specific Effect on Obesity

Guclu-Geyik F., ÇOBAN N., Can G., Erginel-Unaltuna N.

BIOCHEMICAL GENETICS , vol.58, no.6, pp.935-952, 2020 (SCI-Expanded, Scopus) Sustainable Development

21. [Association of APOA5-1131T>C polymorphism with obesity in coronary artery disease].

ÇOBAN N., Ozuynuk A. S., Erkan A. F., Ekici B., Kasit M., Unaltunal N.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , vol.48, no.5, pp.461-471, 2020 (ESCI, Scopus, TRDizin) Sustainable Development

22. Is the effect of rosuvastatin on ABCA1 transporter level direct or indirect?

Coban N., Gulec C.

INTERNATIONAL JOURNAL OF CARDIOLOGY , vol.300, pp.214-216, 2020 (SCI-Expanded)

23. Hsa-miR-584-5p as a novel candidate biomarker in Turkish men with severe coronary artery disease

Coban N., Pirim D., Erkan A. F., Dogan B., Ekici B.

MOLECULAR BIOLOGY REPORTS , 2019 (SCI-Expanded)

24. Macrophage migration inhibitory factor (MIF) gene - 173 G > C polymorphism and its relationship to coronary artery disease and type 2 diabetes

Coban N., Erkan A. F., Ekici B., Kasit M., Unaltuna N., Vurgun E.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.47, no.1, pp.29-37, 2019 (ESCI) Sustainable Development

25. Spermatozoa ve embriyoların gen ekspresyon analizi öncesinde RNA izolasyonu ve hücresel RNA miktarlarının belirlenmesi

Özsait Selçuk B. Ş., ÇOBAN N., SEVER KAYA D., BULGURCUOĞLU KURAN S., Türkölmez S., DURAL Ö.

İSTANBUL TIP FAKÜLTESİ DERGİSİ , vol.81, pp.119-126, 2018 (TRDizin)

26. Effect of ACSL4 gene polymorphism (rs7886473) on metabolic syndrome and lipid levels

Vurgun E., Diker I. Y., Coban N., Geyik F., Guven G., Unaltuna N.

CUKUROVA MEDICAL JOURNAL , vol.43, pp.151-157, 2018 (ESCI, TRDizin) Sustainable Development

27. Evaluation of Dystrophin Gene Deletion Patterns in a Large Duchene/Becker Msuscular Dystrophy Patient Sample; 17 Years Experience from one Turkish Diagnostic Center

PODA M., GUCLU-GEYIK F., ÇOBAN N., TÜYSÜZ B., Güven G., BAYRAK E. K., et al.

Deneysel Tıp Dergisi , vol.7, no.14, pp.50-61, 2017 (Peer-Reviewed Journal)

28. Lower circulating migration inhibitory factor protein is associated with metabolic syndrome and diabetes

Onat A., Ademoglu E., Can G., Coban N., Kaya A., Yuksel H.

BIOMARKERS IN MEDICINE , vol.11, no.7, pp.557-568, 2017 (SCI-Expanded, Scopus) Sustainable Development

29. Role of simvastatin and ROR alpha activity in the macrophage apoptotic pathway

Coban N., Gulec Ç., Selcuk B. O., Erginel-Unaltuna N.

ANATOLIAN JOURNAL OF CARDIOLOGY , vol.17, no.5, pp.362-366, 2017 (SCI-Expanded, Scopus, TRDizin)

30. Identification of potential target genes of ROR-alpha in THP1 and HUVEC cell lines.

Gulec C., Coban N., Ozsait-Selcuk B. Ş., Sirma-Ekmekci S., Yildirim O., Erginel-Unaltuna N.

Experimental cell research , vol.353, pp.6-15, 2017 (SCI-Expanded, Scopus)

31. Investigating the role of ceramide metabolism-associated CERS5 (LASS5) gene in atherosclerosis pathogenesis in endothelial cells

Coban N., GEYIK F., Yıldırım O., UNALTUNA N. E.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.45, no.2, pp.118-125, 2017 (ESCI, Scopus, TRDizin)

32. CYP19A1, MIF and ABCA1 genes are targets of the ROR alpha in monocyte and endothelial cells

Coban N., Gulec Ç., Ozsait-Selcuk B., Erginel-Unaltuna N.

CELL BIOLOGY INTERNATIONAL , vol.41, no.2, pp.163-176, 2017 (SCI-Expanded, Scopus) Sustainable Development

33. KORONER ARTER HASTALIĞI OLMAYAN VE STATİN İLE TEDAVİ EDİLEN BIREYLERDE AMPK YOLAĞINDAYENI BIR ADAYMODÜLATÖR OLARAK MICRORNA-625-5P

Çoban N., Pirim D., Erkan A. F., Geyik F., Ekici B., Ünaltuna N.

Deneysel Tıp Araştırma Enstitüsü Dergisi , vol.6, no.11, pp.11-20, 2016 (Peer-Reviewed Journal)

34. Risk of obesity and metabolic syndrome associated with FTO gene variants discloses clinically relevant gender difference among Turks

Guclu-Geyik F., Onat A., Yuzbasiogullari A. B., Coban N., Can G., Lehtimaki T., et al.

MOLECULAR BIOLOGY REPORTS , vol.43, no.6, pp.485-494, 2016 (SCI-Expanded, Scopus) Sustainable Development

35. Lipoprotein(a) level and MIF gene variant predict incident metabolic syndrome and mortality

Onat A., Can G., Coban N., Donmez I., Cakir H., Ademoglu E., et al.

JOURNAL OF INVESTIGATIVE MEDICINE , vol.64, no.2, pp.392-399, 2016 (SCI-Expanded, Scopus) Sustainable Development

36. Kardiyomiyopatiye Neden Olna Kardiyak Troponin T Gne Mutasyonlarının Araştırılması

GEYİK F., BAYRAK A. E., Bayrak F., ÇOBAN N., ÖZTUNÇ E. F., ÜNALTUNA N.

Deneysel Tıp Araştırma Enstitüsü Dergisi , vol.4, no.10, pp.17-24, 2016 (Peer-Reviewed Journal)

37. Sex- and Obesity-specific Association of Aromatase (CYP19A1) Gene Variant with Apo lipoprotein B and Hypertension

Coban N., Onat A., Guclu-Geyik F., Can G., Erginel-Unaltuna N.

ARCHIVES OF MEDICAL RESEARCH , vol.46, no.7, pp.564-571, 2015 (SCI-Expanded, Scopus) Sustainable Development

38. Oxidative stress-mediated (sex-specific) loss of protection against type-2 diabetes by macrophage migration inhibitory factor (MIF)-173G/C polymorphism

Coban N., Onat A., Yildirim O., Can G., Erginel-Unaltuna N.

CLINICA CHIMICA ACTA , vol.438, pp.1-6, 2015 (SCI-Expanded, Scopus) Sustainable Development

39. Low "quotient" Lp(a) Concentration Mediates Autoimmune Activation and Independently Predicts Cardiometabolic Risk

Onat A., Coban N., Can G., Yueksel M., KARAGOEZ A., Yueksel H., et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.123, no.1, pp.11-18, 2015 (SCI-Expanded, Scopus)

40. 15 Yıllık Huntington Hastalığı Test Sonuçları ve Literatürdeki HH Test Kılavuzları

BAYRAK A. E., PODA M., GÜVEN Z. G., GEYİK F., ÇOBAN N., GÜLEÇ Ç., et al.

Deneysel Tıp Araştırma Enstitüsü Dergisi , vol.5, no.10, pp.10-16, 2015 (Peer-Reviewed Journal)

41. Negative results in screening for possible new sequence variations on ATP-binding cassette transporter A1 gene in Turkish adults with metabolic syndrome

ÇOBAN N., ONAT A., GEYİK F., ERGINEL-UENALTUNA N.

Turk Kardiyol Dern Ars , pp.524-530, 2014 (Peer-Reviewed Journal)

42. Ateroskleroz Gelişiminde Genetik Faktörlerin Rolü.

ÇOBAN N., ERGINEL-UENALTUNA N.

Deneysel Tıp Araştırma Enstitüsü Dergisi , vol.4, no.7, pp.3-12, 2014 (Peer-Reviewed Journal)

43. Gender-specific associations of the APOA1-75G > A polymorphism with several metabolic syndrome components in Turkish adults

Coban N., Onat A., Guclu-Geyik F., Komurcu-Bayrak E., Can G., Erginel-Unaltuna N.

CLINICA CHIMICA ACTA , vol.431, pp.244-249, 2014 (SCI-Expanded, Scopus) Sustainable Development

44. Gender specific association of ABCA1 gene R219K variant in coronary disease risk through interactions with serum triglyceride elevation in Turkish adults

Coban N., Onat A., Bayrak E. K., Gulec Ç., Can G., Unaltuna N.

ANATOLIAN JOURNAL OF CARDIOLOGY , vol.14, no.1, pp.18-25, 2014 (SCI-Expanded)

45. Minor allele of the APOA4 gene T347S polymorphism predisposes to obesity in postmenopausal Turkish women

Guclu-Geyik F., Onat A., Coban N., Komurcu-Bayrak E., Sansoy V., Can G., et al.

MOLECULAR BIOLOGY REPORTS , vol.39, no.12, pp.10907-10914, 2012 (SCI-Expanded, Scopus)

46. Gender- and obesity-specific effect of apolipoprotein C3 gene (APOC3)-482C > T polymorphism on triglyceride concentration in Turkish adults

Coban N., Onat A., Guclu-Geyik F., Komurcu-Bayrak E., Sansoy V., HERGENÇ G., et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE , vol.50, no.2, pp.285-292, 2012 (SCI-Expanded, Scopus)

47. APOC3-482C > T polymorphism, circulating apolipoprotein C-III and smoking: Interrelation and roles in predicting type-2 diabetes and coronary disease

Onat A., Erginel-Unaltuna N., Coban N., CICEK G., Yuksel H.

CLINICAL BIOCHEMISTRY , vol.44, pp.391-396, 2011 (SCI-Expanded, Scopus) Sustainable Development

48. The S447X variant of lipoprotein lipase gene is associated with metabolic syndrome and lipid levels among Turks.

KOMURCU-BAYRAK E., ONAT A., PODA M., HUMPHRIES S. E., ACHARYA J., HERGENC G., et al.

Clinica chimica acta; international journal of clinical chemistry , vol.383, pp.110-5, 2007 (SCI-Expanded, Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 71

1. Investigation of genetic variations in ion channel genes in chronic thromboembolic pulmonary hypertension patients

EKİCİ B., ERTUĞRUL A. S., İNCİ E., KOÇAK A., GÜLEÇ Ç., KÖSEOĞLU BÜYÜKKAYA P., et al.

European Society of Cardiology Congress 2025, Spain, 29 August - 01 September 2025, (Summary Text)

2. ABCA3 and NOTCH1 mRNA Expressions Differ in Chronic Thromboembolic Pulmonary Hypertension Patients with Rare Missense Variants

ÇOBAN N., İNCİ E., ERTUĞRUL A. S., EKİCİ B., GÜLEÇ Ç., KÖSEOĞLU BÜYÜKKAYA P., et al.

European Human Genetics Conference 2025, Italy, 24 - 27 May 2025, (Summary Text)

3. TTN Varyantları ile Birliktelik Gösteren Multifaktöriyel Kronik Tromboembolik Pulmoner Hipertansiyon: Olgu Sunumu

EKİCİ B., ERTUĞRUL A. S., İNCİ E., GÜLEÇ Ç., KOÇAK A., KÖSEOĞLU BÜYÜKKAYA P., et al.

Kardiyolojide Nadir Hastalıklar; Genetikten Tedaviye Yeni Ufuklar Sempozyumu, İzmir, Turkey, 28 February - 01 March 2025, (Summary Text)

4. Alfa Talasemi ile İlişkili Pulmoner Hipertansiyon, Bir Olgu Sunumu

ÇOBAN N., ERTUĞRUL A. S., İNCİ E., GÜLEÇ Ç., KOÇAK A., KÖSEOĞLU BÜYÜKKAYA P., et al.

Kardiyolojide Nadir Hastalıklar; Genetikten Tedaviye Yeni Ufuklar Sempozyumu, İzmir, Turkey, 28 February - 01 March 2025, (Summary Text)

5. Examining ferroptosis indicators in the neuroblastoma cell line

Köseoğlu-Büyükkaya P., Çoban N.

57th European Society of Human Genetics (ESHG) Conference, Berlin, Germany, 1 - 04 June 2024, pp.1197-1198, (Summary Text)

6. Gene polymorphisms of angiopoietin-like protein 8 and plasminogen activator inhibitor-1 as potential effector of CAD

Bilgin A. G., Ekici B., Erkan A. F., Çoban N.

57th European Society of Human Genetics (ESHG) Conference, Berlin, Germany, 1 - 04 June 2024, pp.1001, (Summary Text)

7. Genetic variants in EDN1 and PAI-1 and their role in coronary artery disease susceptibility and clinical outcomes

Çoban N., Özuynuk-Ertuğrul A. S., Erkan A. F., Ekici B., Koçak A.

40. Ulusal Kardiyoloji Kongresi, Antalya, Turkey, 6 - 10 November 2024, pp.80, (Summary Text)

8. Whole Exome Sequencing of Turkish Patients with Idiopathic Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Çoban N., Ekici B., Özuynuk-Ertuğrul A. S., Güleç Ç., İnci E., Koçak A., et al.

40. Ulusal Kardiyoloji Kongresi, Antalya, Turkey, 6 - 10 November 2024, pp.41, (Summary Text)

9. EXPRESSION LEVEL OF CERAMIDE SYNTHASE 5 (CERS5) GENE IN THE EPICARDIAL ADIPOSE TISSUE OF CORONARY ARTERY DISEASE PATIENTS

Çoban N., Bilgin A. G., Özuynuk-Ertuğrul A. S., Köseoğlu-Büyükkaya P., Balkanay O. O., Yıldız C. E.

92nd European Atherosclerosis Society Congress, Lyon, France, 26 - 29 May 2024, pp.39, (Summary Text)

10. ERASTIN-INDUCED FERROPTOSIS ALTERS GENE EXPRESSION LEVELS OF SREBF2 AND SLC25A1 IN MACROPHAGES

Özuynuk-Ertuğrul A. S., Ünaltuna N., Çoban N.

92nd European Atherosclerosis Society Congress, Lyon, France, 26 - 29 May 2024, pp.10, (Summary Text)

11. The combined effects of ANGPTL8 (rs2278426), APOC1 (rs11568822), and APOA5 (rs662799) polymorphisms on CAD risk factors

Bilgin A. G., Özuynuk-Ertuğrul A. S., Ekici B., Erkan A. F., Çoban N.

9th International Congress of Molecular Medicine, 18 - 20 December 2023, pp.12, (Summary Text)

12. AMPK alpha-1 and TNFA gene expression levels are associated with myocardial infarction markers

Özuynuk-Ertuğrul A. S., Doğan N., Yıldız C. E., Balkanay O. O., Çoban N.

9th International Congress of Molecular Medicine, 18 - 20 December 2023, pp.18, (Summary Text)

13. HEPG2 Hücre Hattında Ferroptoz ile İlişkili Genlerin Ekspresyon Değişimlerinin İncelenmesi

Köseoğlu-Büyükkaya P., Özuynuk-Ertuğrul A. S., Çoban N., Erginel-Ünaltuna N.

18.Tıbbi Biyoloji ve Genetik Kongresi, Ankara, Turkey, 26 - 29 October 2023, pp.26, (Summary Text)

14. Anjiyopoietin Benzeri Protein 8 Rs2278426’nın Minör Alleli Koroner Arter Hastalığı ve Tip 2 Diyabetes Mellitus Patoloji Mekanizmalarını Etkiler

Bilgin A. G., Özuynuk-Ertuğrul A. S., Erkan A. F., Ekici B., Çoban N.

18. Tıbbi Biyoloji ve Genetik Kongresi, Ankara, Turkey, 26 - 29 October 2023, pp.29, (Summary Text) Sustainable Development

15. EPICARDIAL AND VISCERAL ADIPOSE TISSUE EXPRESSION LEVELS OF MIR-1247-5P AND PGC-1Α GENE AREASSOCIATED WITH OBESITY

Çoban N., Doğan N., Özuynuk-Ertuğrul A. S., Geyik F., Kırşan C. B., Yıldız C. E., et al.

91st European Atherosclerosis Society Congress, Mannheim, Germany, 21 - 24 May 2023, (Unpublished)

16. Coronary artery disease severity scores and lipid levels are associated with ANRIL polymorphisms in female patients

Kırşan C. B., Bayrak A. E., Özuynuk-Ertuğrul A. S., Erkan A. F., Çoban N.

38th National Cardiology Congress,, Antalya, Turkey, 10 - 13 November 2022, vol.26, pp.24, (Summary Text)

17. Circulating miR-126, miR-210 and let-7g are differentially expressed in MI patients and associated with lipid levels

Çoban N., Özuynuk-Ertuğrul A. S., Ekici B., Erkan A. F.

38th NATIONAL CARDIOLOGY CONGRESS,, Antalya, Turkey, 10 - 13 November 2022, vol.26, pp.157, (Full Text)

18. The lipid ratios and lipid levels are associated with the combination of NOS3 and APOE gene polymorphisms in coronary artery disease

Özuynuk A. S., Erkan A. F., Doğan N., Ekici B., Ünaltuna N., Kurmuş Ö., et al.

37th Turkish Cardiology Congress With International Participation, Antalya, Turkey, 18 - 21 November 2021, vol.25, pp.50, (Summary Text)

19. VARIANTS IN THE 3 ' UNTRANSLATED REGION OF CARDIOVASCULAR-DISEASE RELATED GENES MAY BE INVOLVED IN TYPE 2 DIABETES MELLITUS THROUGH AFFECTING MIRNA BINDING SITES

ÇOBAN N., GÜLEÇ Ç., ERKAN A. F.

89th European Atherosclerosis Society Virtual Congress, Helsinki, Finland, 30 May 2021, vol.331, (Summary Text) Sustainable Development

20. THE EFFECTS OF CLUSTERIN GENE VARIANT ON CORONARY ARTERY DISEASE RISK FACTORS

Özuynuk A. S., Erkan A. F., Doğan N., Ekici B., Kurmuş Ö., Ünaltuna N., et al.

89th European Atherosclerosis Society Virtual Congress, 30 May - 02 June 2021, vol.331, pp.217, (Summary Text)

21. Normozoospermi, teratozoospermi ve oligoteratozoospermi olgularında spermatozoal RNA miktarının embriyo gelişimi üzerine etkisi

Özsait Selçuk B. Ş., Sever Kaya D., Bulgurcuoğlu Kuran S., Çoban N.

14. Ulusal Tıbbi Genetik Kongresi, İstanbul, Turkey, 20 - 22 November 2020, pp.9, (Summary Text)

22. Association of itln1 gene polymorphism in coronary artery disease with type 2 diabetes

Geyik F., Özuynuk A. S., Erkan A. F., Ekici B., Çoban N.

88th European Atherosclerosis Society Congress, 4 - 07 October 2020, vol.315, pp.127, (Summary Text)

23. miR-130b and miR- 18a correlated with stenosis and lipid levels in CAD patients

Çoban N., Özuynuk A. S., Erkan A. F., Geyik F., Ekici B.

36.Uluslararası Katılımlı Türk Kardiyoloji Kongresi, 3 - 06 December 2020, vol.24, pp.95, (Summary Text)

24. Association of NOS3 G894T polymorphism with coronary artery disease in individuals with or without diabetes mellitus

Özuynuk A. S., Erkan A. F., Ekici B., Ünaltuna N., Çoban N.

88th European Atherosclerosis Society Congress, 4 - 07 October 2020, vol.315, pp.176, (Summary Text) Sustainable Development

25. AMP-activated protein kinase regulates expression of macrophage migration inhibitory factor and MIR-18A in HUVEC

Özuynuk A. S., Çoban N.

88th European Atherosclerosis Society Congress, 4 - 07 October 2020, vol.315, pp.30, (Summary Text)

26. ANRIL Gen Varyantlarının Ateroskleroz Yaygınlığı ve Ciddiyeti İle İlişkileri

Şentürk H., Çoban N., Oksen D., Keskin B., Yıldız M., Bayrak A. E.

14. Uluslararası Katılımlı Ulusal Tıbbi Genetik Kongresi, Ankara, Turkey, 20 - 22 November 2020, pp.23, (Summary Text)

27. Variants in the 3’untranslated region of the CXCL12 gene may mediate the miRNA function in coronary artery disease

Çoban N., Pirim D., Fahri A., Ekici B.

Uluslararası Katılımlı 35. Türk Kardiyoloji Kongresi, Antalya, Turkey, 2 - 06 October 2019, pp.1-2, (Summary Text)

28. The role RORalpha target genes in postmortem advanced atherosclerotic plaques and patients with CAD

Çoban N., Özuynuk A. S., Erkan A. F., Cavlak M., Ünaltuna N.

7th INTERNATIONAL CONGRESS of THE MOLECULAR BIOLOGY ASSOCIATION of TURKEY, İstanbul, Turkey, 27 - 29 September 2019, pp.124, (Summary Text)

29. Hsa-miR-584-5p as a novel candidate biomarker in Turkish men with coronary artery disease.

Çoban N., Pirim D., Doğan B., Erkan A. F., Ekici B.

Uluslararası Katılımlı 35. Türk Kardiyoloji Kongresi, Antalya, Turkey, 2 - 06 October 2019, pp.3-4, (Summary Text)

30. The effect of APOA5 -1131T>C polymorphism on plasma lipid levels in Turkish coronary artery disease patients

Çoban N., Kaşit M., Erkan A. F., Özuynuk A. S., Ünaltuna N., Ekici B.

7th International Congress of Molecular Medicine, İstanbul, Turkey, 5 - 07 September 2019, pp.131, (Summary Text)

31. AMPK ACTIVATION DECREASES EXPRESSION OF MIR-130B IN ENDOTHELIAL CELLS

Coban N., Ozuynuk A. S., Erginel-Unaltuna N.

87th Congress of the European-Atherosclerosis-Society (EAS), Maastricht, Netherlands, 26 - 29 May 2019, vol.287, (Summary Text)

32. CORONARY ARTERY DISEASE RELATED MIR-19A AND MIR-26A ARE SENSITIVE TO SIMVASTATIN AND ROR-ALPHA LIGANDS IN MACROPHAGE CELLS

Coban N., Gulec Ç., Ozuynuk A. S., Erginel-Unaltuna N., Erkan A. F.

87th Congress of the European-Atherosclerosis-Society (EAS), Maastricht, Netherlands, 26 - 29 May 2019, vol.287, (Summary Text)

33. IDENTIFICATION OF MIRNA PROFILING IN EPICARDIAL ADIPOSE TISSUE OF PATIENTS WITH ATHEROSCLEROSIS

Guclu-Geyik F., Koseoglu P., OZSOY S. D., CETIN H. K., BALKANAY O. O., YILDIZ C. E., et al.

87th Congress of the European-Atherosclerosis-Society (EAS), Maastricht, Netherlands, 26 - 29 May 2019, vol.287, (Summary Text)

34. Role of miR-18a and miR-584 on AMPK Pathway in Endothelial Cells

ÇOBAN N., OZUYNUK A. S.

13 th Balkan Congress of Human Genetics, Edirne, Turkey, 17 - 20 April 2019, pp.103, (Summary Text)

35. Silencing of CERS5 (Ceramide synthase 5) alters the protein and gene expression of atherosclerosis related genes in endothelial cells

OZUYNUK A. S., GUCLU-GEYIK F., KOSEOGLU P., ERGINEL-UNALTUNA N., ÇOBAN N.

13. Tıbbi Genetik Kongresi,, Muğla, Turkey, 7 - 11 November 2018, pp.185, (Full Text)

36. Genetic risk factors for coronary artery disease that are specific to Turkish population

ÇOBAN N., OZUYNUK A. S., ERKAN A. F., Ekici B., ERGINEL-UENALTUNA N., Vurgun E.

Turkish Cardiology Congress 2018, Antalya, Turkey, 19 October 2018 - 22 October 2019, pp.113, (Summary Text)

37. A novel mirsnp at the IGF1 3'UTR may modulate the mirna-mediated gene expression in cardiovascular disease

Pirim D., ÇOBAN N., Erkan A. F., Ekici B., UNALTUNA N. E., Diker İ. Y., et al.

EAS Congress 2018, Lisbon, Portugal, 4 - 09 May 2018, vol.275, (Full Text) Sustainable Development

38. Berberinin AMP-aktive edilmiş protein kinaz yolağında bulunan seçilmiş genlerin ekspresyon düzeylerine etkisi

Çelebi G., Kalkan M. A., Çoban N., Özsait Selçuk B. Ş., Vural B., Bayrak A. E.

XV. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 26 - 29 October 2017, pp.12, (Summary Text)

39. AMP-Aktive edilmiş Protein Kinazın (AMPK) Aktivatörü-AICAR kullanımının AMPK yolağındaki genler üzerine etkisi

Kalkan M. A., Çelebi G., Çoban N., Özsait Selçuk B. Ş., Vural B., Bayrak A. E.

XV. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 26 - 29 October 2017, pp.27, (Summary Text)

40. miRNA Aracili Gen Regulasyonunda PTEN Geninin 3'UTR Bölgesindeki Dizi Varyantlarinin Rolü

ÇOBAN N., Pirim D., Erkan A. F., GÜÇLÜ G. F., Ekici B., ERGINEL-UNALTUNA N., et al.

Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 26 - 21 October 2017, pp.1, (Full Text)

41. Investigation of the association between ITLN1 gene A326T polymorphism and in subjects with type 2 diabetes mellitus and obese: In the TARF study.

GEYİK F., ONAT A., CAN G., ÇOBAN N., KOMURCU-BAYRAK E., ERGINEL-UNALTUNA N., et al.

American Society of Human Genetics Congress, Orlando, United States Of America, 17 - 21 October 2017, pp.2, (Full Text) Sustainable Development

42. The effects of missense mutations causing PRKAG2 cardiomyopathy on expression levels of selected genes involved in AMPK pathway.

KOMURCU-BAYRAK E., Kalkan M., Çelebi G., ÇOBAN N., OZSAIT-SELCUK B., VURAL B., et al.

American Society of Human Genetics Congress, Orlando, United States Of America, 17 - 21 October 2017, pp.1, (Full Text)

43. Investigation of microRNA expression in coronary artery disease.

ÇOBAN N., Pirim D., Erkan A. F., GEYİK F., Ekici B., ERGINEL-UNALTUNA N., et al.

American Society of Human Genetics Congress, Orlando, United States Of America, 17 - 21 October 2017, pp.3, (Full Text)

44. THE ROLE OF CYP19A1, ESR1 AND MIF GENES POLYMORPHIMS ON THE ANGIOGRAPHIC SEVERITY AND THE EXTENT OF ATHEROSCLEROTIC CORONARY ARTERY DISEASE

Coban N., Kaya A., Erkan A. F., Guclu-Geyik F., Ekici B., Ademoglu E., et al.

85th Congress of the European-Atherosclerosis-Society (EAS), Prague, Czech Republic, 23 - 26 April 2017, vol.263, (Summary Text)

45. The Role of CYP19A1, ESR1 and MIF Genes Polymorphıms On The Angıographıc Severıty and The Extent of Atherosclerotıc Coronary Artery Dısease.

ÇOBAN N., KAYA A., ERKAN A. F., GÜÇLÜ GEYİK F., EKİCİ B., ADEMOĞLU E., et al.

85th The European Atherosclerosis Society (EAS) Congress, PRAG, Czech Republic, 23 - 26 April 2017, vol.263, pp.3120, (Summary Text)

46. Serum Apolipoprotein E Levels are Higher in Individuals With Atherosclerotic Coronary Artery Disease When Compared to Those Without: Presentation of Preliminary Findings.

Erkan A. F., Coban N., Ekici B., Kurmus O., Uzunget S. B., Kaya A., et al.

13th International Congress of Update in Cardiology and Cardiovascular Surgery (UCCVS), Cesme, Turkey, 23 - 26 March 2017, vol.119, (Summary Text)

47. Serum Levels of Adiponectin Are Not Related to Angiographic Presence or Severity of Atherosclerotic Coronary Artery Disease.

Erkan A. F., Coban N., Ekici B., Kurmus O., Uzunget S. B., Kaya A., et al.

13th International Congress of Update in Cardiology and Cardiovascular Surgery (UCCVS), Cesme, Turkey, 23 - 26 March 2017, vol.119, (Summary Text)

48. Plasma levels of miR 19a miR 26a and miR 584 are associated with severity of coronary artery disease in Turkish Men.

ÇOBAN N., Pirim D., Erkan A. F., GEYİK F., Ekici B., ÜNALTUNA N.

The American Society of Human Genetics Conference 2016, Vancouver, Canada, 17 - 21 October 2016, (Full Text)

49. Deletion and duplication patterns of dystophin gene in Turkish DuchenneBecker muscular dystrophy patients.

GUCLU-GEYIK F., ÇOBAN N., ERGINEL-UNALTUNA N., GEYİK F.

European Human Genetics Conference 2016,, Barcelona, Spain, 20 - 24 May 2016, pp.7, (Full Text)

50. MicroRNA-625-5p as a novel candidate modulator of AMPK pathway in statin-treated individuals without coronary artery disease

ÇOBAN N.

European Human Genetics Conference 2016, Barcelona, Spain, 20 - 24 May 2016, pp.6, (Full Text)

51. Role of ceramide synthase 5 gene (LASS/CERS5) in molecular pathogenesis of atherosclerosis

Çoban N., Yıldırım O., Geyik F., Özsait Selçuk B. Ş., Ünaltuna N.

ESHG 2015, Glasgow, England, 6 - 09 June 2015, pp.123, (Summary Text)

52. 14 Yıllık Huntington Hastalığı Genetik Tanı Sonuçlarının Değerlendirilmesi

KÖMÜRCÜ BAYRAK E., PODA M., GÜVEN Z. G., GEYİK F., ÇOBAN N., GÜLEÇ Ç., et al.

6. DETAE Günleri, Turkey, 24 November 2014, (Summary Text)

53. Macrophage migration inhibitory factor (MIF) gene polymorphism tends to predict type-2 diabetes risk in Turkish men, not women: implications

ÇOBAN N., ONAT A., Yıldırım Ö., CAN G., ERGINEL-UNALTUNA N.

30. Uluslararası Katılımlı Ulusal Kardiyoloji Kongresi, Antalya, Turkey, 23 - 26 October 2014, pp.111, (Summary Text) Sustainable Development

54. Simvastatin affects ABCA1 expression and cholesterol efflux in THP-1 macrophages by a ROR-Alpha-dependent pathway.

ÇOBAN N., Güleç Ç., Özsait B., ERGINEL-UNALTUNA N.

European Human Genetics Conference, Milan, Italy, 31 May - 03 June 2014, pp.102, (Full Text)

55. FTO gene rs1421085 polymorphism is associated with obesity and metabolic syndrome in the Turkish adults

GEYİK F., Yüzbaşıogulları A., ONAT A., ÇOBAN N., CAN G., Lehtimaki t., et al.

European Human Genetics Conference 2014, Milano, Italy, 31 May - 03 June 2014, (Full Text) Sustainable Development

56. Genetic Variation in LPA Gene Predicts Plasma Lipoprotein(a) Level and Type 2 Diabetes Risk

Coban N., Onat A., Can G., Unaltuna N. E.

29th Turkish Cardiology Congress of the Turkish-Society-of-Cardiology (TSC) with International Participation, Antalya, Turkey, 26 - 29 October 2013, vol.62, (Summary Text) Sustainable Development

57. A Genetic Variant Associated with Lipoprotein(a) Level and Coronary Disease Risk in Turkish Adults

Coban N., Onat A., Can G., Unaltuna N.

29th Turkish Cardiology Congress of the Turkish-Society-of-Cardiology (TSC) with International Participation, Antalya, Turkey, 26 - 29 October 2013, vol.62, (Summary Text)

58. Gene-Gene Interaction between APOA4 and FTO for Obesity in TARF Study

Geyik F., Coban N., Yuzbasiogullari B., Onat A., Sansoy V., Gunay C., et al.

29th Turkish Cardiology Congress of the Turkish-Society-of-Cardiology (TSC) with International Participation, Antalya, Turkey, 26 - 29 October 2013, vol.62, (Summary Text)

59. Inhibitory Effect of SR1001 on ROR-Alpha Activity Requires Intracellular Cholesterol

GÜLEÇ Ç., Çoban N., Özsait B., Sirma-Ekmekçi S., Erginel-Ünaltuna N.

European Human Genetics Conference, Paris, France, 8 - 11 July 2013, pp.461, (Full Text)

60. ROR alpha target genes in monocyte and endothelium.

Unaltuna Erginel N., Güleç Ç., Çoban N., Özsait B., Sırma Ekmekci S.

European Human Genetics Conference 2013, Paris, France, 08 June 2014, vol.21, pp.460, (Summary Text)

61. Türk erişkinlerinde APOE ε2/ε3/ε4 ve APOA4 T347S polimorfizmlerinin obezite üzerine etkileri

Geyik F., Bayrak A. E., Onat A., Çoban N., Poda M., Can G., et al.

27. Ulusal Kardiyoloji Kongresi, İstanbul, Turkey, 27 - 30 October 2011, pp.61, (Summary Text) Sustainable Development

62. Türk erişkinlerinde açlık trigliserit düzeylerine APOA1/C3/A4/A5 gen kümesinin etkisi

Bayrak A. E., Onat A., Çoban N., Geyik F., Poda M., Can G., et al.

27. Ulusal Kardiyoloji Kongresi, İstanbul, Turkey, 27 - 30 October 2011, pp.59, (Summary Text) Sustainable Development

63. TEKHARF çalışmasında dislipidemi ve apolipoprotein genleri

Çoban N., Bayrak A. E., Onat A., Geyik F., Can G., Ünaltuna N.

27. Ulusal Kardiyoloji Kongresi, İstanbul, Turkey, 27 - 30 October 2011, pp.60, (Summary Text)

64. Association found between the promoter region polymorphism in the APOC3 gene and the serum triglyceride level in Tukish adults

Geyik F., Çoban N., Onat A., Bayrak A. E., Sansoy V., Hergenç G., et al.

9. Ulusal Tıbbi Genetik Kongresi, İstanbul, Turkey, 1 - 05 December 2010, pp.26, (Summary Text)

65. . The effect of APOA4-T347S polymorphism on obesity and serum triglycerides in Turkish adults

Geyik F., Çoban N., Onat A., Bayrak A. E., Sansoy V., Hergenç G., et al.

9. Ulusal Tıbbi Genetik Kongresi , İstanbul, Turkey, 1 - 05 December 2010, pp.25, (Summary Text)

66. Tekharf Çalışmasında Metabolik Sendrom Gelişimini Etkileyen Genetik Risk Faktörlerinin Belirlenmesi

Ünaltuna N., Bayrak A. E., Çoban N., Onat A., Güleç Ç., Poda M., et al.

26. Ulusal Kardiyoloji Kongresi, İstanbul, Turkey, 21 - 24 October 2010, pp.22, (Summary Text)

67. TEKHARF çalışması ile IL-6 promotor gen varyantlarının ilişkileri

Geyik F., Poda M., Onat A., Bayrak A. E., Çoban N., Hergenç G., et al.

XXIV. Ulusal Kardiyoloji Kongresi, İstanbul, Turkey, 24 - 27 October 2009, pp.121, (Summary Text)

68. Türk erişkinlerinde Apolipoprotein AIV gen polimorfizminin plazma lipid seviyeleri ve obezite ile ilişkisi

Geyik F., Çoban N., Onat A., Bayrak A. E., Hergenç G., Erginel N.

XXV. Ulusal Kardiyoloji Kongresi, İstanbul, Turkey, 22 - 25 October 2009, pp.49, (Summary Text) Sustainable Development

69. Türk erişkinlerinde apolipoprotein C3 geninin abdominal obezite ile ilişkisi

Çoban N., Geyik F., Onat A., Bayrak A. E., Hergenç G., Sansoy V., et al.

XXV. Ulusal Kardiyoloji Kongresi, İstanbul, Turkey, 22 - 25 October 2009, pp.45, (Summary Text) Sustainable Development

70. ATP-binding Kaset Transporter A1 (ABCA1) Geninin Düşük HDL-kolesterol Seviyesi Üzerine Etkisi

Çoban N., Onat A., Bayrak A. E., Can G., Ünaltuna N.

XXIII. Ulusal Kardiyoloji Kongresi, Antalya, Turkey, 19 - 23 October 2007, pp.32, (Summary Text)

71. Metabolik Sendromda Lipoprotein Lipaz Geni S447X Varyantının Önemi

KÖMÜRCÜ BAYRAK E., PODA M., ONAT A., HERGENÇ G., ÇOBAN N., CAN G., et al.

XXII. Ulusal Kardiyoloji Kongresi, Turkey, 24 - 28 November 2006, (Summary Text)

Books 7

Metrics

Publication

126

Publication (WoS)

Publication (Scopus)

Citation (WoS)

272

H-Index (WoS)

Citation (Scopus)

306

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

Publications & Works

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

H-Index (WoS)

Citation (Scopus)

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Project

Thesis Advisory

Open Access